Novozymes
Novonesis, formed through the combination of Novozymes A/S and Chr. Hansen, is a Danish global biosolutions company producing industrial enzymes and microbes. The company researches, manufactures, and markets biological solutions including enzymes, probiotics, cultures, and proteins for food, beverage, agriculture, household care, and human health. Main revenue drivers comprise global sales of biological enzymes and microbial ingredients to consumer goods and industrial processing companies. Novonesis serves food and beverage producers, detergent manufacturers, animal nutrition companies, bioenergy plants, and pharmaceutical firms globally. The company holds a world-dominant market position as the largest global provider of industrial enzymes and biosolutions. Headquartered in Bagsvaerd, Denmark, Novonesis is listed on Nasdaq Copenhagen.
6 of the funds FundTelligence covers report a position in Novozymes.
- Legal name
- Novozymes A/S
- Sector
- Materials
- Country
- Denmark
- Funds holding it
- 6
- Exposure themes
- Circular Economy, Circular Materials & Resource Efficiency, Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals
Funds holding Novozymes
- BNP Europe Growth Capitalisation — BNP Paribas · 3.48 % (largest positions only, October 2026)
- Pareto Nordic Equity — Pareto · 3.39 % (full portfolio disclosed, June 2026)
- BNP Climate Change — BNP Paribas · 3.25 % (largest positions only, October 2026)
- DWS Invest Focus Europe — DWS · 1.55 % (full portfolio disclosed, June 2026)
- BNP Europe Equity — BNP Paribas · 1.28 % (full portfolio disclosed, December 2025)
- DWS Invest ESG Climate Opportunities — DWS · 0.99 % (full portfolio disclosed, June 2026)